Review of Clinical Integration Program

We represented a healthcare company in evaluating a potential clinical integration program.

You Also May Be Interested In:

  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019. Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its acquisition of Alion Science & Technology Corporation's Naval Systems Business Unit, including its Canadian...
    Client Type: Private Company
  • Represented Quest Diagnostics in its acquisition of the Outreach Laboratory Service Operations of Marin General Hospital

    We represented Quest Diagnostics (NYSE: DGX) in its acquisition of the outreach laboratory services operations of Marin General Hospital, a non-profit, full-service...
    Client Type: Public Company
  • Successful representation of Medsurant LLC in appeal to vacate $18.8 million dollar jury verdict in case alleging tortious interference

    We successfully represented Medsurant LLC in an appeal to vacate an $18.8 million dollar jury verdict in a case alleging...
    Client Type: Private Company